Joint Letter on COVID-19 and Cancer
The Cancer Drug Development Forum fully supports the European Cancer Patient Coalition's initiative, Joint Letter on COVID-19 and Cancer, and calls for the action to identify the impact of the pandemic on cancer services and design services to mitigate this. CLICK...
CDDF 12th Spring Conference meeting report is now available!
The CDDF 12th Spring Conference took place on 8-10 February 2021, virtually. This multi-stakeholder, interactive meeting offered plenary lectures with moderated discussions, including case studies as well as networking opportunities. The programme focused on the...
NEW CDDF INDUSTRY PARTNER – Varian Medical Systems
Varian Medical Systems becomes first medical technology company to join The Cancer Drug Development Forum (CDDF). We welcome Varian to the CDDF Industry Partners Platform and look forward to great collaboration in 2021! To read...
NEW CDDF brochure
CDDF has been published its NEW CDDF brochure. Click the link to read the latest version.
HAPPY HOLIDAY SEASON!
Unlocking the Value of Personalised Cancer Care
Access to Personalised Oncology in Europe, a new report by LSE consulting commissioned by EFPIA, identifies the barriers to better deployment of personalised cancer treatment for European cancer patients and makes concrete recommendations on how to advance and...